Xylazine Pharmacology and Prevalence: Application to the Clinical Setting


The webinar Xylazine Pharmacology and Prevalence: A Clinical Perspective is geared towards clinicians and laboratory management seeking to better understand xylazine, its effects on humans and related clinical interventions.


After this presentation, participants will be able to:

  • Describe the prevalence of xylazene in the drug supply
  • Compare the pharmacology and pharmacokinetics of xylazine to opioids of misuse
  • Describe factors that complicate the ability to reverse the effects of xylazine
  • Develop an appropriate management strategy for patients experiencing xylazine withdrawal



Sherri Kacinko

Sherri Kacinko, Ph.D., F-ABFT

Toxicologist V
NMS Labs, Horsham, PA

Dr. Sherri Kacinko has been a forensic toxicologist at NMS Labs toxicologist team in Horsham, PA for over 15 years. She earned her B.S in Chemistry from the University of Pittsburgh (Johnstown) and her Ph.D. in toxicology from the University of Maryland – Baltimore. She also serves as an Instructor at the Center for Forensic Science Research & Education where she lectures in pharmacology, postmortem toxicology, and human performance toxicology courses. Current research interests include the identification and quantification of novel psychoactive substances and esoteric drugs and the use of data analytics to monitor drug use trends on a local and national level. 

Dr. Kacinko is a fellow of the American Board of Forensic Toxicology (ABFT) and is a member of the Society of Forensic Toxicologists (SOFT), the International Association of Forensic Toxicologists (TIAFT), the American Academy of Forensic Sciences (AAFS), and holds a Certificate of Qualifications from the New York State Department of Health. She was presented with the American Academy of Forensic Sciences Toxicology Section Irving Sunshine Award in recognition of early career research and served as the program chair, secretary and chair of the AAFS toxicology section. 

Lauren A. Igneri,

Lauren A. Igneri, PharmD, BCPS, BCCCP, FCCM

Clinical Pharmacy Specialist, Critical Care
Cooper University Healthcare (CUH), Camden, NJ 

Lauren earned her Doctor of Pharmacy degree from the Ernest Mario School of Pharmacy at Rutgers University. She completed a PGY1 Pharmacy Practice Residency at Temple University Hospital in Philadelphia, Pennsylvania followed by a PGY2 Critical Care Specialty Residency at University of the Sciences in Philadelphia with her main practice site at CUH. Following residency, Lauren was the Critical Care Clinical Pharmacy Specialist at St. Mary Medical Center (SMMC) in Langhorne, Pennsylvania. 

Lauren is involved in numerous multidisciplinary committees to improve the care of critically ill patients. She serves as a primary preceptor for the critical care residents’ rotation, research, and continuing education experiences. Lauren is a member of several professional societies, including the Society of Critical Care Medicine and contributes regularly within the Clinical Pharmacy and Pharmacology Communications Committee. In 2019, she was elected Member at Large of the Women in Critical Care KEG. Additionally, Lauren is a member of the American Society of Health-System Pharmacists and American College of Clinical Pharmacy. She has served as faculty creating educational materials for ASHP’s board recertification resources since 2016.

Sponsored by:

NMS Labs Clinical Division